tiprankstipranks
Aptose Biosciences (TSE:APS)
TSX:APS
Canadian Market
APS
Aptose Biosciences
RESEARCH TOOLSreports

Aptose Biosciences (APS) Cash flow

145 Followers

Aptose Biosciences Cash Flow

TSE:APS's free cash flow for Q4 2025 was $-5.93M. For the 2025 fiscal year, TSE:APS's free cash flow was decreased by $13.61M and operating cash flow was $-5.93M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -22.37M$ -35.98M$ -44.59M$ -32.32M$ -43.30M
Investing Cash Flow
$ 0.00$ 18.00K$ 9.96M$ 30.07M$ -35.21M
Financing Cash Flow
$ 19.72M$ 33.41M$ 6.91M$ 116.00K$ 226.00K
End Cash Position
$ 4.09M$ 6.71M$ 9.25M$ 36.97M$ 39.11M
Free Cash Flow
$ -22.37M$ -35.98M$ -44.62M$ -32.35M$ -43.52M
Currency in USD

Aptose Biosciences Cash Flow